Concepedia

Ali Golshayan

AG

Statistics

Publications

13

Citations

4.3K

H-Index

12

Active since

2004

Affiliations

Cleveland Clinic(Current)

Medical University of South Carolina

MUSC Hollings Cancer Center

Cancer Institute (WIA)

Cleveland Clinic Lerner College of Medicine

Ali Golshayan is an author at Cleveland Clinic specializing in medicine, oncology, and metastasis.

Publications per year

2004–2013

13

Publications

13

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · Journal of Clinical Oncology · 2009 · 2.1K citations · Full text

, , +17

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

Jennifer S. Ko, Arnold H. Zea, Brian I. Rini et al. · Clinical Cancer Research · 2009 · 852 citations

, , +17

Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

James H. Finke, Brian I. Rini, Joanna Ireland et al. · Clinical Cancer Research · 2008 · 485 citations

, , +17

Clinical factors associated with outcome in patients with metastatic clear‐cell renal cell carcinoma treated with vascular endothelial growth factor‐targeted therapy

Toni K. Choueiri, Jorge A. García, Paul Elson et al. · Cancer · 2007 · 231 citations · Full text

, , +17

Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Therapy

Ali Golshayan, Saby George, Daniel Yick Chin Heng et al. · Journal of Clinical Oncology · 2008 · 229 citations · Full text

, , +10

1–5 of 13